Contribution ofBRCA1andBRCA2mutations to inherited ovarian cancer
- 9 August 2007
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 28 (12) , 1207-1215
Abstract
A total of 283 epithelial ovarian cancer families from the United Kingdom (UK) and the United States (US) were screened for coding sequence changes and large genomic alterations (rearrangements and deletions) in the BRCA1 and BRCA2 genes. Deleterious BRCA1 mutations were identified in 104 families (37%) and BRCA2 mutations in 25 families (9%). Of the 104 BRCA1 mutations, 12 were large genomic alterations; thus this type of change represented 12% of all BRCA1 mutations. Six families carried a previously described exon 13 duplication, known to be a UK founder mutation. The remaining six BRCA1 genomic alterations were previously unreported and comprised five deletions and an amplification of exon 15. One of the 25 BRCA2 mutations identified was a large genomic deletion of exons 19–20. The prevalence of BRCA1/2 mutations correlated with the extent of ovarian and breast cancer in families. Of 37 families containing more than two ovarian cancer cases and at least one breast cancer case with diagnosis at less than 60 years of age, 30 (81%) had a BRCA1/2 mutation. The mutation prevalence was appreciably less in families without breast cancer; mutations were found in only 38 out of 141 families (27%) containing two ovarian cancer cases only, and in 37 out of 59 families (63%) containing three or more ovarian cancer cases. These data indicate that BRCA1 and BRCA2 are the major susceptibility genes for ovarian cancer but that other susceptibility genes may exist. Finally, it is likely that these data will be of clinical importance for individuals in families with a history of epithelial ovarian cancer, in providing accurate estimates of their disease risks. Hum Mutat 28(12), 1207–1215, 2007.Keywords
This publication has 32 references indexed in Scilit:
- The contribution of germline rearrangements to the spectrum of BRCA2 mutationsJournal of Medical Genetics, 2006
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genesBritish Journal of Cancer, 2002
- The Exon 13 Duplication in the BRCA1 Gene Is a Founder Mutation Present in Geographically Diverse PopulationsThe American Journal of Human Genetics, 2000
- Risk models for familial ovarian and breast cancerGenetic Epidemiology, 2000
- Mutation nomenclature extensions and suggestions to describe complex mutations: A discussionHuman Mutation, 1999
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998
- Recommendations for a nomenclature system for human gene mutationsHuman Mutation, 1998
- Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 geneNature Genetics, 1997
- Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlationNature Genetics, 1995